Bausch Health Companies Inc (BHC)
8.18
-0.01
(-0.12%)
USD |
NYSE |
Nov 21, 16:00
8.185
0.00 (0.00%)
Pre-Market: 20:00
Bausch Health Profit Margin (Quarterly): -3.39% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -3.39% |
| June 30, 2024 | 0.42% |
| March 31, 2024 | -2.97% |
| December 31, 2023 | -1.62% |
| September 30, 2023 | -16.89% |
| June 30, 2023 | 1.20% |
| March 31, 2023 | -10.34% |
| December 31, 2022 | -18.70% |
| September 30, 2022 | 19.50% |
| June 30, 2022 | -7.37% |
| March 31, 2022 | -3.60% |
| December 31, 2021 | 3.14% |
| September 30, 2021 | 8.91% |
| June 30, 2021 | -28.33% |
| March 31, 2021 | -30.09% |
| December 31, 2020 | -6.91% |
| September 30, 2020 | 3.32% |
| June 30, 2020 | -19.59% |
| March 31, 2020 | -7.55% |
| December 31, 2019 | -68.17% |
| September 30, 2019 | -2.22% |
| June 30, 2019 | -7.95% |
| March 31, 2019 | -2.58% |
| December 31, 2018 | -16.22% |
| September 30, 2018 | -16.39% |
| Date | Value |
|---|---|
| June 30, 2018 | -41.02% |
| March 31, 2018 | -129.4% |
| December 31, 2017 | 23.72% |
| September 30, 2017 | 58.63% |
| June 30, 2017 | -1.70% |
| March 31, 2017 | 29.78% |
| December 31, 2016 | -21.43% |
| September 30, 2016 | -49.13% |
| June 30, 2016 | -12.48% |
| March 31, 2016 | -15.77% |
| December 31, 2015 | -14.00% |
| September 30, 2015 | 1.78% |
| June 30, 2015 | -1.94% |
| March 31, 2015 | 4.50% |
| December 31, 2014 | 22.61% |
| September 30, 2014 | 13.39% |
| June 30, 2014 | 6.16% |
| March 31, 2014 | -1.20% |
| December 31, 2013 | 6.00% |
| September 30, 2013 | -63.13% |
| June 30, 2013 | 0.99% |
| March 31, 2013 | -2.57% |
| December 31, 2012 | -9.69% |
| September 30, 2012 | 0.86% |
| June 30, 2012 | -2.63% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-68.17%
Minimum
Dec 2019
19.50%
Maximum
Sep 2022
-9.45%
Average
-5.26%
Median
Profit Margin (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 21.17% |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -2.12K% |
| Xenon Pharmaceuticals Inc | -- |
| ESSA Pharma Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -0.66% |
| Return on Invested Capital | -0.82% |
| Gross Profit Margin (Quarterly) | 72.27% |
| Operating Margin (Quarterly) | 21.08% |
| Return on Net Operating Assets | -0.79% |